Global consumer healthcare company iNova Pharmaceuticals continues its growth trajectory in Asia with the Philippine launch of DURO-TUSS®, a science-backed cough solution that joins iNova’s growing product portfolio in the country.
The launch event gathered healthcare professionals and medical experts to introduce the brand’s commitment to providing proven, effective, and reliable cough relief for Filipino families.
Tailored Relief for Every Type of Cough
DURO-TUSS® is available in two powerful formulations designed to target specific cough types:
Butamirate Citrate (DURO-TUSS BCS)
Available in:
? 60ml Syrup
? 50mg Sustained-Release Tablet
Butamirate Citrate (DURO-TUSS BCS) provides dual action relief by suppressing cough and easing breathing, making it ideal for dry cough.
Ambroxol Hydrochloride (DURO-TUSS AXS)
Available in:
? 60ml Syrup
? 75mg Sustained-Release Tablet
Ambroxol Hydrochloride (DURO-TUSS AXS) offers triple action relief for cough with phlegm, it thins and loosens mucus, clears chest congestion, and protects the lungs from phlegm buildup.
DURO-TUSS® is now available at leading pharmacies nationwide. It carries a comprehensive range of prescription and over-the-counter cough relief medications tailored to treat either dry cough or cough with phlegm.